Clinicopathologic characteristics, prognostic and predictive biomarkers in adult T-cell leukemia/lymphoma (ATLL): A characterization of 79 cases from the Western Hemisphere
Alejandro A. Gru(University of Virginia), Jonathan J. Davick(University of Iowa), José Antônio Sanches(Universidade de São Paulo), Melissa Pulitzer(Memorial Sloan Kettering Cancer Center), Lee Ratner(Washington University in St. Louis), Sandro Casavilca‐Zambrano(Institute for Anthropological Research), Daniela Dueñas(Instituto Nacional de Enfermedades Neoplásicas), Denis Miyashiro(Peter MacCallum Cancer Centre), O. Servitje(Bellvitge University Hospital), Eli S. Williams(University of Virginia), Carlos Barrionuevo(National University of San Marcos), Fina Climent
Cited by 0
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
|Journal of Clinical Oncology|2015|419
Multidrug resistance transporters and modulation
|Current Opinion in Oncology|2000|383